Novartis Pharma AG (Gold Sponsor)
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2017, the Group achieved net sales of USD 49.1 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. For more information, please visit http://www.novartis.com.
GC Pharma (Silver Sponsor)
107, Ihyeon-ro 30beon-gil,
Giheung-gu, Yongin-si, Gyeonggi-do,
Republic of Korea
GREEN CROSS CORP
In 1971, GC Pharma (formerly known as Green Cross Corporation) became the first company in S.Korea and the sixth company in the world to establish a plasma fractionation plant. In 2009, it completed the construction of the Ochang Plant, the largest biotech facility at the time. GC Pharma has been producing and exporting a variety of plasma-derived products, including albumin, immunoglobulin, and antithrombin. The company has acquired unparalleled expertise in plasma fractionation, and continues to research and develop safer and ever more effective next-generation products.
Prevention of disease is another priority at GC Pharma. In 1983, the company became the third in the world to develop a hepatitis-B vaccine, known as Hepavax, followed by in 1988 becoming the first in the world to develop a vaccine against the Hantavirus hemorrhagic fever (Hantavax). In 1993, GC Pharma became the second in the world to develop a varicella vaccine (Suduvax), and in 2015 it became the fourth in the world to develop a quadrivalent flu vaccine (GC Flu Quadrivalent), thereby establishing itself as a world-class leader in vaccine development.
Biotest is a provider of plasma proteins and biological drugs. With a value added chain that extends from pre-clinical and clinical development to worldwide sales, Biotest has specialised primarily in the areas of clinical immunology, haematology and intensive medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. In addition, Biotest develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest has more than 2,500 employees worldwide. The preference shares of Biotest AG are listed in the SDAX on the Frankfurt stock exchange.
180 Hartwell Rd
01730 Bedford, MA
Instrumentation Laboratory (IL) develops and manufactures instruments, reagents and data management solutions, to help hospitals enhance patient care and efficiency. The IL booth features products from the IL Acute Care Diagnostics (ACD) portfolio, for laboratory and point-of-care (POC) testing, including ROTEM sigma and delta viscoelastic testing systems, VerifyNow platelet aggregation systems and Hemochron POC Hemostasis systems. Other key products in the IL ACD portfolio include GEM Premier blood gas systems, Avoximeter CO-Oximeters and GEMweb Plus Custom Connectivity. IL is a Werfen company.